[18F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response
Abstract The growing interest and clinical translation of alpha particle (α) therapies brings with it new challenges to assess target cell engagement and to monitor therapeutic effect. Noninvasive imaging has great potential to guide α-treatment and to harness the potential of these agents in the co...
Main Authors: | Hanwen Zhang, Diane Abou, Peng Lu, Abbie Meghan Hasson, Alexandria Villmer, Nadia Benabdallah, Wen Jiang, David Ulmert, Sean Carlin, Buck E. Rogers, Norman F. Turtle, Michael R. McDevitt, Brian Baumann, Brian W. Simons, Farrokh Dehdashti, Dong Zhou, Daniel L. J. Thorek |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-17460-0 |
Similar Items
-
Prostate Cancer Theranostics - An Overview
by: Diane Abou, et al.
Published: (2020-06-01) -
Molecular Imaging of ACE2 Expression in Infectious Disease and Cancer
by: Zhiyao Li, et al.
Published: (2023-09-01) -
Carbon nanotubes exhibit fibrillar pharmacology in primates.
by: Simone Alidori, et al.
Published: (2017-01-01) -
Emerging treatments for metastatic castration-resistant prostate cancer: Immunotherapy, PARP inhibitors, and PSMA-targeted approaches
by: Catherine Handy Marshall, et al.
Published: (2020-01-01) -
Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry
by: Nadia Benabdallah, et al.
Published: (2023-02-01)